Show simple item record

dc.contributor.authorEdwards, Zoe*
dc.contributor.authorBlenkinsopp, Alison*
dc.contributor.authorZiegler, Lucy*
dc.contributor.authorBennett, M.*
dc.date.accessioned2016-05-12T15:07:43Z
dc.date.available2016-05-12T15:07:43Z
dc.date.issued2016-04
dc.identifier.citationEdwards Z, Blenkinsopp A, Zeigler L and Bennett M (2016) Cancer patients’ views on community pharmacy pain medicines consultations in advanced cancer [oral abstract]. International Journal of Pharmacy Practice, Volume 24, Supplement S1, page 22.en_US
dc.identifier.urihttp://hdl.handle.net/10454/8346
dc.description-en_US
dc.description.abstractEvery year in England and Wales, 105,000 people sufferfrom uncontrolled cancer pain and are rarely offered community pharmacy medicine consultations (e.g. Medicines Use Reviews -MURs)[1]. Our aim was to examine how patients with cancer pain deal with their pain medication and to investigate their experiences of and attitudes towards community pharmacy.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://onlinelibrary.wiley.com/doi/10.1111/ijpp.12258/abstracten_US
dc.subjectCancer pain, Pharmacy medicine consultations, Pain medication, Patients, Experiences, Attitudesen_US
dc.titleCancer patients’ views on community pharmacy pain medicines consultations in advanced canceren_US
dc.status.refereedn/aen_US
dc.date.application2016-03-21
dc.typeOtheren_US
dc.type.versionNo full-text available in the repositoryen_US


This item appears in the following Collection(s)

Show simple item record